In another victory on behalf of Axinn’s client Alvogen, a district court affirmed a previous court ruling that both Alvogen and Dr. Reddy’s Laboratories can move forward with antitrust counterclaims against Indivior. The counterclaims arise from a dispute over generic versions of Suboxone, Indivior’s opioid addition treatment. The Axinn team included Matt Becker, Pete Herrick, Ted Mathias, Susan Zhu and David Ludwig.
Axinn Team Prevails for Alvogen in Suboxone Antitrust Litigation
August 26, 2020